Suppr超能文献

MRAP2抑制β-抑制蛋白2募集至前动力蛋白受体2。

MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2.

作者信息

Lattanzi Roberta, Casella Ida, Fullone Maria Rosaria, Maftei Daniela, Vincenzi Martina, Miele Rossella

机构信息

Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.

National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.

出版信息

Curr Issues Mol Biol. 2024 Feb 17;46(2):1607-1620. doi: 10.3390/cimb46020104.

Abstract

Melanocortin receptor accessory protein 2 (MRAP2) is a membrane protein that binds multiple G protein-coupled receptors (GPCRs) involved in the control of energy homeostasis, including prokineticin receptors. These GPCRs are expressed both centrally and peripherally, and their endogenous ligands are prokineticin 1 (PK1) and prokineticin 2 (PK2). PKRs couple all G-protein subtypes, such as Gαq/11, Gαs, and Gαi, and recruit β-arrestins upon PK2 stimulation, although the interaction between PKR2 and β-arrestins does not trigger receptor internalisation. MRAP2 inhibits the anorexigenic effect of PK2 by binding PKR1 and PKR2. The aim of this work was to elucidate the role of MRAP2 in modulating PKR2-induced β-arrestin-2 recruitment and β-arrestin-mediated signalling. This study could allow the identification of new specific targets for potential new drugs useful for the treatment of the various pathologies correlated with prokineticin, in particular, obesity.

摘要

黑皮质素受体辅助蛋白2(MRAP2)是一种膜蛋白,它能结合多种参与能量稳态控制的G蛋白偶联受体(GPCR),包括促动力蛋白受体。这些GPCR在中枢和外周均有表达,其内源配体是促动力蛋白1(PK1)和促动力蛋白2(PK2)。促动力蛋白受体与所有G蛋白亚型偶联,如Gαq/11、Gαs和Gαi,并在PK2刺激时募集β-抑制蛋白,尽管PKR2与β-抑制蛋白之间的相互作用不会触发受体内化。MRAP2通过结合PKR1和PKR2来抑制PK2的厌食作用。这项工作的目的是阐明MRAP2在调节PKR2诱导的β-抑制蛋白2募集和β-抑制蛋白介导的信号传导中的作用。这项研究可能有助于识别潜在新药的新特异性靶点,这些新药可用于治疗与促动力蛋白相关的各种疾病,尤其是肥胖症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/235b/10887741/dc056399d147/cimb-46-00104-sch001.jpg

相似文献

1
MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2.
Curr Issues Mol Biol. 2024 Feb 17;46(2):1607-1620. doi: 10.3390/cimb46020104.
2
Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
J Biol Chem. 2023 Jan;299(1):102814. doi: 10.1016/j.jbc.2022.102814. Epub 2022 Dec 17.
3
Prokineticin receptors interact unselectively with several G protein subtypes but bind selectively to β-arrestin 2.
Cell Signal. 2021 Jul;83:110000. doi: 10.1016/j.cellsig.2021.110000. Epub 2021 Mar 31.
5
Mapping the interaction site for β-arrestin-2 in the prokineticin 2 receptor.
Cell Signal. 2024 Jul;119:111175. doi: 10.1016/j.cellsig.2024.111175. Epub 2024 Apr 15.
6
MRAP2a Binds and Modulates Activity and Localisation of Prokineticin Receptor 1 in Zebrafish.
Int J Mol Sci. 2024 Jul 17;25(14):7816. doi: 10.3390/ijms25147816.
8
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
Neuropeptides. 2018 Oct;71:32-42. doi: 10.1016/j.npep.2018.06.005. Epub 2018 Jun 28.
9
Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling.
Biochim Biophys Acta Mol Cell Res. 2017 Dec;1864(12):2322-2329. doi: 10.1016/j.bbamcr.2017.09.008. Epub 2017 Sep 20.
10
Role of N-Linked Glycosylation in PKR2 Trafficking and Signaling.
Front Neurosci. 2021 Aug 13;15:730417. doi: 10.3389/fnins.2021.730417. eCollection 2021.

本文引用的文献

1
Mapping the interaction site for β-arrestin-2 in the prokineticin 2 receptor.
Cell Signal. 2024 Jul;119:111175. doi: 10.1016/j.cellsig.2024.111175. Epub 2024 Apr 15.
2
Novel Insights into Prokineticin 1 Role in Pregnancy-related Diseases.
Int J Med Sci. 2024 Jan 1;21(1):27-36. doi: 10.7150/ijms.76817. eCollection 2024.
3
Structure, function and drug discovery of GPCR signaling.
Mol Biomed. 2023 Dec 4;4(1):46. doi: 10.1186/s43556-023-00156-w.
4
Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2303794120. doi: 10.1073/pnas.2303794120. Epub 2023 Oct 16.
5
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.
Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8.
6
Single transmembrane GPCR modulating proteins: neither single nor simple.
Protein Cell. 2024 May 28;15(6):395-402. doi: 10.1093/procel/pwad035.
7
Inputs and Outputs of the Mammalian Circadian Clock.
Biology (Basel). 2023 Mar 28;12(4):508. doi: 10.3390/biology12040508.
8
-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.
Pharmacol Rev. 2023 Sep;75(5):854-884. doi: 10.1124/pharmrev.121.000302. Epub 2023 Apr 7.
9
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins.
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
10
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors.
Curr Issues Mol Biol. 2022 Dec 12;44(12):6323-6332. doi: 10.3390/cimb44120431.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验